We are live on ! Find out more
MESO

Mesoblast
MESO

43 hedge funds and large institutions have $12.4M invested in Mesoblast in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

430% more call options, than puts

Call options by funds: $6.75M | Put options by funds: $1.27M

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

27% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 11

23% more capital invested

Capital invested by funds: $10.1M → $12.4M (+$2.32M)

10% more funds holding

Funds holding: 39 → 43 (+4)

0.01% more ownership

Funds ownership: 0.13% → 0.14% (+0.01%)

Holders
43
Holders Change
+4
Holders Change %
+10.26%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
14
Reduced
11
Closed
4
Calls
$6.75M
Puts
$1.27M
Net Calls
+$5.48M
Net Calls Change
+$4.59M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$611K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$299K
3
XC
XY Capital
Hong Kong
+$203K
4
Jane Street
Jane Street
New York
+$183K
5
Group One Trading
Group One Trading
Illinois
+$174K

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$440K
2
CIC
Chase Investment Counsel
Virginia
-$405K
3
Citadel Advisors
Citadel Advisors
Florida
-$253K
4
Wells Fargo
Wells Fargo
California
-$176K
5
PM
Penbrook Management
New York
-$120K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$90.3K +$5.63K +829 +8%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$90.1K +$74.8K +11,025 New
Cambridge Investment Research Advisors
28
Cambridge Investment Research Advisors
Iowa
$90K -$10.2K -1,500 -12%
CSS
29
Cubist Systematic Strategies
Connecticut
$84.3K +$70.1K +10,321 New
TFA
30
Tobias Financial Advisors
Florida
$81.7K – – –
AP
31
Advisors Preferred
Maryland
$53K -$2.57K -378 -6%
S
32
SignatureFD
Georgia
$45K +$21K +3,099 +129%
GI
33
GAMMA Investing
California
$44.9K +$3.51K +517 +10%
QCG
34
Quadrant Capital Group
Ohio
$37.6K -$8.74K -1,288 -22%
LC
35
Lindbrook Capital
California
$10.4K -$1.73K -255 -17%
CLOS
36
Compagnie Lombard Odier SCmA
Switzerland
$8.17K – – –
WSFS
37
Wilmington Savings Fund Society
Delaware
$7.01K +$5.83K +858 New
National Bank of Canada
38
National Bank of Canada
Quebec, Canada
$4.29K +$3.56K +525 New
PA
39
Parallel Advisors
California
$2.04K -$3.44K -506 -67%
BTI
40
Blue Trust Inc
Georgia
$994 +$686 +101 +224%
EWA
41
EverSource Wealth Advisors
Alabama
$605 +$502 +74 New
Osaic Holdings
42
Osaic Holdings
Arizona
$261 – – –
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$25 +$20 +3 New
CIC
44
Chase Investment Counsel
Virginia
– -$405K -59,600 Closed
CF
45
Cantor Fitzgerald
New York
– -$110K -16,195 Closed
XT
46
XTX Topco
Cayman Islands
– -$103K -15,063 Closed
Comerica Bank
47
Comerica Bank
Texas
– -$6.76K -993 Closed
1
2

MESO Hedge Fund Activity: Q3 2024 in Review

43 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q3 2024, worth a combined $12.4M — up 23% from $10.1M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new MESO positions and 4 closed out — a net gain of 5 holders — while 14 added to existing stakes and 11 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $611K. The largest seller was Marshall Wace, cutting an estimated $440K.

  • 43 institutional investors held Mesoblast (MESO) as of Q3 2024, up from 39 in Q2 2024.
  • Funds reported $12.4M of Mesoblast stock for Q3 2024, up 23% quarter-over-quarter.
  • 9 funds opened new Mesoblast positions in Q3 2024 and 4 closed out, a net change of +5 holders.
  • The largest Mesoblast buyer in Q3 2024 was Morgan Stanley, an estimated $611K added.
  • The largest Mesoblast seller in Q3 2024 was Marshall Wace, an estimated $440K sold.

Based on aggregated 13F filings for Q3 2024.